Chemoinformaics analysis of Apigenin-7-Di-O-Xyloside
| Molecular Weight | 566.468 | nRot | 5 |
| Heavy Atom Molecular Weight | 540.26 | nRig | 30 |
| Exact Molecular Weight | 566.127 | nRing | 5 |
| Solubility: LogS | -3.677 | nHRing | 3 |
| Solubility: LogP | -0.608 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 66 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 40 | No. of Aromatic Carbocycles | 2 |
| nHetero | 15 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 25 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 15 | No. of Arom Bond | 17 |
| nHA | 15 | APOL | 71.1166 |
| nHD | 9 | BPOL | 35.6314 |
| QED | 0.159 |
| Synth | 4.655 |
| Natural Product Likeliness | 1.674 |
| NR-PPAR-gamma | 0.857 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.977 |
| HIA | 0.939 |
| CACO-2 | -6.293 |
| MDCK | 0.0000904 |
| BBB | 0.197 |
| PPB | 0.801379 |
| VDSS | 0.596 |
| FU | 0.150446 |
| CYP1A2-inh | 0.013 |
| CYP1A2-sub | 0.021 |
| CYP2c19-inh | 0.021 |
| CYP2c19-sub | 0.054 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.669 |
| CYP2d6-inh | 0.009 |
| CYP2d6-sub | 0.171 |
| CYP3a4-inh | 0.01 |
| CYP3a4-sub | 0.004 |
| CL | 1.005 |
| T12 | 0.379 |
| hERG | 0.037 |
| Ames | 0.654 |
| ROA | 0.016 |
| SkinSen | 0.015 |
| Carcinogencity | 0.757 |
| EI | 0.009 |
| Respiratory | 0.026 |
| NR-Aromatase | 0.908 |
| Antiviral | Yes |
| Prediction | 0.810879 |